Skip to content
GenoLensGenoLens

THBD

Chr 20p11.21

thrombomodulin

Aliases:
CD141, THRM, BDCA-3
MANE:
ENST00000377103.3

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Bleeding and platelet disorders

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • COVID-19 research

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Inherited bleeding disorders

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Thrombophilia with a likely monogenic cause

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Atypical haemolytic uraemic syndrome

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Primary immunodeficiency or monogenic inflammatory bowel disease

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Disease associations (Open Targets)

  • atypical hemolytic-uremic syndrome with thrombomodulin anomaly

    0.73
  • thrombomodulin-related bleeding disorder

    0.72
  • Venous thrombosis

    0.52
  • atypical hemolytic-uremic syndrome

    0.42
  • Abnormal bleeding

    0.39
  • complement deficiency

    0.37
  • Thrombocytopenia

    0.35
  • venous thromboembolism

    0.32
  • neurodegenerative disease

    0.31
  • Abnormal thrombosis

    0.27

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Thrombomodulin

Endothelial cell receptor that plays a critical role in regulating several physiological processes including hemostasis, coagulation, fibrinolysis, inflammation, and angiogenesis (PubMed:10761923). Acts as a cofactor for thrombin activation of protein C/PROC on the surface of vascular endothelial cells leading to initiation of the activated protein C anticoagulant pathway (PubMed:29323190, PubMed:33836597, PubMed:9395524). Also accelerates the activation of the plasma carboxypeptidase B2/CPB2, which catalyzes removal of C-terminal basic amino acids from its substrates including kinins or anaphylatoxins leading to fibrinolysis inhibition (PubMed:26663133). Plays critical protective roles in changing the cleavage specificity of protease-activated receptor 1/PAR1, inhibiting endothelial cell permeability and inflammation (By similarity). Suppresses inflammation distinctly from its anticoagulant cofactor activity by sequestering HMGB1 thereby preventing it from engaging cellular receptors such as RAGE and contributing to the inflammatory response (PubMed:15841214)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.